<DOC>
	<DOCNO>NCT00738361</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , paclitaxel albumin-stabilized nanoparticle formulation , work different way stop growth tumor cell , either kill cell stop dividing . PURPOSE : This phase II trial study well paclitaxel albumin-stabilized nanoparticle formulation work treat patient metastatic melanoma eye remove surgery .</brief_summary>
	<brief_title>Paclitaxel Albumin-Stabilized Nanoparticle Formulation Treating Patients With Metastatic Melanoma Eye That Can Be Removed By Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - To evaluate overall response rate patient unresectable , metastatic uveal melanoma treat paclitaxel albumin-stabilized nanoparticle formulation . Secondary - To determine median progression-free survival patient treat regimen . - To determine overall survival patient treat regimen . OUTLINE : Patients receive paclitaxel albumin-stabilized nanoparticle formulation IV 30 minute day 1 , 8 , 15 . Courses repeat every 28 day absence disease progression unacceptable toxicity . After completion study therapy , patient follow every 8 week 1 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Histologically cytologically confirm evidence metastatic/ unresectable uveal melanoma Measurable disease , define least one lesion accurately measure least one dimension ≥10 mm spiral CT scan 18 year old Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 No know HIV Hepatitis B C Patients brain metastasis eligible entry study Patients must normal organ/marrow function define : Absolute neutrophil count ≥ 1.5 x 109/L Platelets ≥ 100,000 x 109/L Hemoglobin ≥ 9.0 gm/100 ml Total bilirubin ≤ 1.5 . In patient Gilbert 's disease indirect bilirubin must less equal 4.0 . AST ALT ≤ 2.5x upper limit normal Alkaline phosphatase ≤ 2.5x upper limit normal , unless bone metastasis present absence liver metastasis Creatinine ≤ 1.8 mg/ml calculate creatinine clearance &gt; 50 mg ml . Calcium &lt; 12 mg/dl correct level serum albumen Patients one prior systemic therapy Chemotherapy radiotherapy within 4 week prior enter study failure recover adverse event due agent administer 4 week earlier . May receive simultaneous investigational agent No prior malignancy except adequately treat basal cell cancer , situ cervical cancer cancer patient disease free 2 year . Patients serious infection major uncontrolled medical illness . Patients significant psychiatric illness opinion principal investigator would prevent adequate inform consent render therapy unsafe . Patients pregnant . Female patient child bear potential must negative serum pregnancy test use adequate contraception protection study . Peripheral neuropathy &gt; grade 2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ciliary body choroid melanoma , medium/large size</keyword>
	<keyword>iris melanoma</keyword>
	<keyword>metastatic intraocular melanoma</keyword>
	<keyword>recurrent intraocular melanoma</keyword>
	<keyword>extraocular extension melanoma</keyword>
</DOC>